InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: friendofthedevil post# 3969

Wednesday, 05/27/2015 3:18:37 PM

Wednesday, May 27, 2015 3:18:37 PM

Post# of 8521
Halo is way past sell stock as part of deal stage. They sold to Roche around $3 and Baxter around $9. Nothing since then.

Since Halo is planning global Phase III and talking to EMA second half. Look for Halo to enter marketing deal for ex-US and not sell the rights to Peg.

Once Peg is approved for one indication, I think we see many pharma's running trials with Peg.

I don't think Halo has any deals or will enter any deals that limit the value to any potential buyer.

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News